Pfizer says the first doses of its Covid-19 booster have already been shipped to 62 locations across the United States.
The Biden administration hopes to make getting a COVID-19 booster as routine as going in for the yearly flu shot
A fourth dose is already authorized in the U.S. for people 50 and older.
Health care providers hoping to get new guidance on coronavirus vaccines from the FDA will have to keep waiting. Wednesday’s meeting ended with no solid answers regarding the future of booster shots and regular vaccines.
DHEC says it is recommending a second COVID-19 booster shot for certain individuals, largely mirroring guidance put out by the CDC on Tuesday.
The CDC has signed off on a second booster shot for people over 50, and the BA.2 subvariant is now the dominant strain in the U.S.
Pfizer is petitioning to the FDA for a second COVID-19 booster shot for older Americans. This comes as we see potential warning signs of a new rise in coronavirus infections.
The pace of Americans getting COVID-19 booster shots has reached a new low, and health experts are concerned.
Pfizer says it is testing an omicron-specific vaccine booster. This comes as the FDA faces backlash over its decision to halt the use of two antibody treatments.
Some states are starting to see infection numbers and hospitalizations drop, but that’s still not the case everywhere.
